May 2016 PMID 26308532

Gynecomastia in Patients with Prostate Cancer: A Systematic Review.

Anders Fagerlund, Luigi Cormio, Lina Palangi, Richard Lewin, Fabio Santanelli di Pompeo, Anna Elander, Gennaro Selvaggi

Mentions

5
Peak: 2 in Apr 2024
across 3 sources since Jun 2021

Extended reach

2,712
potential audience

Total likes

10

Video views

885

Mentions per month

Jun 2021 – Apr 2024

Where it's discussed

  • YouTube2 videos
  • Reddit2 posts
  • X / Twitter1 posts

AI synopsis

What people are saying

The posts show recognition of the review's significance, with statements like 'tamoxifen and radiotherapy are effective options,' and references to how managing gynecomastia can improve patient quality of life. The tone remains thoughtful and informative, emphasizing the review's relevance to treatment strategies and patient outcomes.

AgreementModerate agreement

Most discussions agree with the publication, acknowledging its findings on gynecomastia as a common side effect and the effectiveness of treatments like tamoxifen and radiotherapy.

InterestModerate interest

Users demonstrate moderate interest, discussing the implications for patient quality of life and treatment options without overwhelming technical detail.

EngagementModerate engagement

Participants engage by referencing specific aspects of the review, such as treatment efficacy and side effects, indicating a genuine interest in understanding and applying the information.

ImpactModerate impact

The discourse suggests the publication could influence clinical practices and patient care, as users highlight the importance of managing gynecomastia in prostate cancer treatments.

Abstract in brief

  • Gynecomastia is a common side effect in up to 70% of prostate cancer patients treated with antiandrogens like bicalutamide, impacting their quality of life.
  • The review analyzed 11 studies, mainly involving pharmacological treatments such as tamoxifen and anastrozole, as well as radiotherapy, finding that both are effective options with manageable side effects.
  • Overall, tamoxifen (10-20 mg daily) and radiotherapy are recommended for managing bicalutamide-induced gynecomastia, with tamoxifen being particularly effective for both prevention and treatment.]

Top posts

Most liked on X and Bluesky
Satoru Mitsuboshi
@3stars67664378 · X

Gynecomastia https://t.co/5rODLe9Nwr https://t.co/gbVXdVHG1t https://t.co/RllsUsSSLE Review https://t.co/gbVXdVHG1t https://t.co/Ub9vjKEdXj https://t.co/W5JnQf1UiC https://t.co/T2I0c8GLUj https://t.co/RyeI0wSBD9 https://t.co/p5MPGBgPWm https://t.co/d7C4nTQovc

Jun 9, 2021 · 1,828 followers View post →

All mentions

Hormone Therapy Options for Prostate Cancer Treatment

This 8-minute video provides insights on prostate cancer care focusing on hormone therapy, including the use of LHRH agonists like Goserelin and Leuprolide, and antagonists such as Degarelix, explaining their mechanisms…

StudyMed · Apr 27, 2024 284 views
Satoru Mitsuboshi
@3stars67664378 · X

Gynecomastia https://t.co/5rODLe9Nwr https://t.co/gbVXdVHG1t https://t.co/RllsUsSSLE Review https://t.co/gbVXdVHG1t https://t.co/Ub9vjKEdXj https://t.co/W5JnQf1UiC https://t.co/T2I0c8GLUj https://t.co/RyeI0wSBD9 https://t.co/p5MPGBgPWm https://t.co/d7C4nTQovc

Jun 9, 2021 · 1,828 followers View post →